The clinical laboratory instrumentation (CLI) market in Taiwan is a mature market that is approaching saturation. Taiwan has one of the best healthcare systems in Asia Pacific after Japan and offers both modern and comprehensive medical services to its population. The CLI market in Taiwan was valued at approximately $67.0 million in 2005 and is expected to grow by about 4.0 percent in 2006. The market is expected to experience of compound annual growth rate (CAGR) of 5.9 percent driven by strong growth in molecular diagnostics product segment. Growth in core market segments of clinical chemistry, immunochemistry and hematology remain modest with growth expected to pick up towards the end of the forecast period.
Scope and Segmentation
- Research Scope
- Market Segmentation
Research Methodology
- Methodology
- Key Definitions and Abbreviations
Market Overview
Market Dynamics
- Introduction
- Market Engineering Analysis
Market Forecasts
Technology Trends
Competitive Structure
Competitive Landscape
Strategic Recommendations
Decision Support Database
Speak directly with our analytics experts for tailored recommendations.
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | Yes |
| Podcast | No |
| Industries | Healthcare |
| WIP Number | 4A0F-01-00-00-00 |
| Is Prebook | No |
Taiwanese Clinical Laboratory Instrumentation Markets
12-Oct-2006
Asia Pacific
Market Research